Salvage esophagectomy for persistent disease after definitive chemoradiotherapy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The optimal management of locally advanced cancer of the esophagus remains controversial. Given recent advances in the results of combined concurrent chemoradiation, medical and radiation oncologists are dubious about the additional benefit of surgical resection in patients that respond to non-surgical therapy. However, despite a perceived complete local-regional response, many patients will manifest persistent or recurrent disease that is potentially resectable. This chapter aims to discuss the feasibility and pitfalls of opting for salvage esophagectomy.

Original languageEnglish (US)
Title of host publicationDifficult Decisions in Thoracic Surgery (Second Edition)
Subtitle of host publicationAn Evidence-Based Approach
PublisherSpringer London
Pages233-240
Number of pages8
ISBN (Print)9781849963640
DOIs
StatePublished - 2011

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Salvage esophagectomy for persistent disease after definitive chemoradiotherapy'. Together they form a unique fingerprint.

Cite this